ArticleBlood advances2021
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma.
Chiara Pighi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleBlood advances2021
Chiara Pighi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.